Cisen Pharmaceutical Co., Ltd.
603367.SS
Price:
$13.21
Market Cap:
$5.98B
Cisen Pharmaceutical Co., Ltd. operates as a pharmaceutical enterprise, manufacturing and distributing a diverse portfolio of chemical drug preparations and healthcare products to both domestic and international markets. Founded in 1998 and based in Jining, People's Republic of China, the company offers an extensive range of chemical drug solutions. These include medications for liver diseases, antitumor and supportive treatments, nutritional supplements, contrast agents, antibiotics, digestive system remedies, polypropylene ampoules, and topical preparations. Additionally, their product line encompasses sedation and anesthesia agents, cardiovascular drugs, treatments for cough and asthma, i...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-09-29
Stock Exchange
SHH
Ticker
603367.SS
PE Ratio
[14.68]
ROE
[6.60%]
Current Ratio
[4.65]
Dividend Yield
[2.63%]
Enterprise Value
[5.35B]
Dividend History
The Current Ratio as of June 2026 (TTM) for Cisen Pharmaceutical Co., Ltd. (603367.SS) is 4.65
According to Cisen Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 4.65. This represents a change of 12.06% compared to the average of 4.15 of the last 4 quarters.
Cisen Pharmaceutical Co., Ltd. (603367.SS) Historical Current Ratio (quarterly & annually)
How has 603367.SS Current Ratio performed in the past?
The mean historical Current Ratio of Cisen Pharmaceutical Co., Ltd. over the last ten years is 3.46. The current 4.65 Current Ratio has changed 13.33% with respect to the historical average. Over the past ten years (40 quarters), 603367.SS's Current Ratio was at its highest in in the March 2026 quarter at 4.65. The Current Ratio was at its lowest in in the September 2016 quarter at 0.
Average
3.46
Median
3.48
Minimum
2.04
Maximum
4.27
Cisen Pharmaceutical Co., Ltd. (603367.SS) Current Ratio by Quarter and Year
Discovering the peaks and valleys of Cisen Pharmaceutical Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 64.96%
Maximum Annual Current Ratio = 4.27
Minimum Annual Increase = -27.99%
Minimum Annual Current Ratio = 2.04
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 4.26 | 27.75% |
| 2024 | 3.33 | -8.14% |
| 2023 | 3.63 | -1.99% |
| 2022 | 3.70 | 8.86% |
| 2021 | 3.40 | 10.55% |
| 2020 | 3.08 | -27.99% |
| 2019 | 4.27 | 19.76% |
| 2018 | 3.57 | 6.22% |
| 2017 | 3.36 | 64.96% |
| 2016 | 2.04 | 48.79% |
Cisen Pharmaceutical Co., Ltd. (603367.SS) Average Current Ratio
How has 603367.SS Current Ratio performed in the past?
The current Current Ratio of Cisen Pharmaceutical Co., Ltd. (603367.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.74
5-year avg
3.66
10-year avg
3.46
Cisen Pharmaceutical Co., Ltd. (603367.SS) Current Ratio vs. Peers
How is 603367.SS’s Current Ratio compared to its peers?
Cisen Pharmaceutical Co., Ltd.’s Current Ratio is greater than Tianjin Ringpu Bio-Technology Co.,Ltd. (1.81), greater than KPC Pharmaceuticals, Inc. (2.09), greater than Harbin Pharmaceutical Group Co., Ltd. (1.45), greater than Shandong Xinhua Pharmaceutical Company Limited (1.76), greater than Shandong Lukang Pharmaceutical Co.,Ltd. (1.53), less than Renhe Pharmacy Co., Ltd. (6.58), greater than Zhejiang Xianju Pharmaceutical Co.,Ltd. (3.32), greater than Huapont Life Sciences Co., Ltd. (1.40), greater than Sichuan Huiyu Pharmaceutical Co., Ltd. (2.61), greater than Zhejiang Hisoar Pharmaceutical Co., Ltd. (1.20),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.81 | $7.13B | |
| 2.09 | $6.28B | |
| 1.45 | $7.81B | |
| 1.76 | $6.20B | |
| 1.53 | $6.38B | |
| 6.58 | $7.22B | |
| 3.32 | $8.12B | |
| 1.40 | $8.83B | |
| 2.61 | $6.82B | |
| 1.20 | $8.43B |
Build a custom stock screener for Cisen Pharmaceutical Co., Ltd. (603367.SS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cisen Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cisen Pharmaceutical Co., Ltd. (603367.SS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cisen Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is Cisen Pharmaceutical Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for Cisen Pharmaceutical Co., Ltd. (603367.SS)?
What is the highest Current Ratio for Cisen Pharmaceutical Co., Ltd. (603367.SS)?
What is the 3-year average Current Ratio for Cisen Pharmaceutical Co., Ltd. (603367.SS)?
What is the 5-year average Current Ratio for Cisen Pharmaceutical Co., Ltd. (603367.SS)?
How does the current Current Ratio for Cisen Pharmaceutical Co., Ltd. (603367.SS) compare to its historical average?